Takeda Joins the R&D Migration to Boston

Posted on June 5, 2015 by Alexander Szewczak

From Fierce Biotech, news that the “unending game of global reorganization in biopharma R&D is continuing” with a new move by Takeda to close several vaccine operations around the U.S. in order to concentrate R&D in “the hot Boston/Cambridge, MA hub“

Advertisement
This entry was posted in Biotech, Boston-Cambridge, Pharmaceutical Industry and tagged , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.